Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -2.06 | 33.15 |
| PEG Ratio (TTM) | 0.10 | 11.22 |
| P/S Ratio (TTM) | N/A | 3.09 |
| P/B Ratio (TTM) | 2.66 | 7.21 |
| P/FCF Ratio (TTM) | N/A | 33.93 |
| Price to 5YR AVG Earnings Ratio | -13.73 | 78.36 |
| Price to 5YR AVG FCF Ratio | 39.91 | 604.51 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -64.35% | 8.30% |
| ROE (TTM) | -85.58% | 19.95% |
| Net Profit Margin (TTM) | -23.78% | 7.99% |
| ROIC 5YR AVG | -7.76% | 25.16% |
Growth (45%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -173.90% | 132.07% | -97.12% |
| Revenue | 0.40% | 20.98% | 2.77% |
| Net Income | -175.02% | 127.65% | -102.24% |
| Cash Flow | -249.80% | 107.73% | 31.88% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.24 | 1.26 |
| Quick Ratio (TTM) | 1.14 | 1.04 |
| D/E Ratio (TTM) | 0.13 | 0.37 |
| Interest Coverage (TTM) | -17.70 | 0.03 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | 2.59 | 4.87 |
| LTL to 5YR AVG FCF | 1.85 | 41.71 |
| Shares Outstanding Growth 5YR AVG | 8.79% | 6.88% |